These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Mediastinal lymphadenopathy: Do not forget tularemia!]. Tissot N; Noureddine S; Guion-Dusserre M; Soumagne T Rev Mal Respir; 2021 Feb; 38(2):204-209. PubMed ID: 33581986 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary tularaemia: all that looks like cancer is not necessarily cancer - case report of four consecutive cases. Fachinger P; Tini GM; Grobholz R; Gambazzi F; Fankhauser H; Irani S BMC Pulm Med; 2015 Mar; 15():27. PubMed ID: 25887439 [TBL] [Abstract][Full Text] [Related]
6. Role and interpretation of fluorodeoxyglucose-positron emission tomography/computed tomography in HIV-infected patients with fever of unknown origin: a prospective study. Martin C; Castaigne C; Tondeur M; Flamen P; De Wit S HIV Med; 2013 Sep; 14(8):455-62. PubMed ID: 23517190 [TBL] [Abstract][Full Text] [Related]
7. [A clinical analysis of 40 cases of primary and secondary pulmonary lymphoma]. Niu X; Hu H; Gao J; Nie Y; Zhao W; Xu H; Bai X; Chen L Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jul; 37(7):502-6. PubMed ID: 25262690 [TBL] [Abstract][Full Text] [Related]
8. Biopsy findings in PET/CT-positive lung lesions in a community hospital. Lobrano MB; Hayman E; Dekelbaum M; Campeau R J La State Med Soc; 2005; 157(6):319-24. PubMed ID: 16579344 [TBL] [Abstract][Full Text] [Related]
9. An assessment of So A; Pointon O; Hodgson R; Burgess J Clin Endocrinol (Oxf); 2018 May; 88(5):683-691. PubMed ID: 29446832 [TBL] [Abstract][Full Text] [Related]
11. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis of the presence of lymph node metastasis and decision of operative indication using fluorodeoxyglucose-positron emission tomography and computed tomography in patients with primary lung cancer. Toba H; Kondo K; Otsuka H; Takizawa H; Kenzaki K; Sakiyama S; Tangoku A J Med Invest; 2010 Aug; 57(3-4):305-13. PubMed ID: 20847531 [TBL] [Abstract][Full Text] [Related]
13. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Gould MK; Kuschner WG; Rydzak CE; Maclean CC; Demas AN; Shigemitsu H; Chan JK; Owens DK Ann Intern Med; 2003 Dec; 139(11):879-92. PubMed ID: 14644890 [TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics and Outcome of Pathologic N0 Non-small Cell Lung Cancer Patients With False Positive Mediastinal Lymph Node Metastasis on FDG PET-CT. Kim KY; Park HL; Kang HS; Lee HY; Yoo IR; Lee SH; Yeo CD In Vivo; 2021; 35(3):1829-1836. PubMed ID: 33910869 [TBL] [Abstract][Full Text] [Related]
16. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer]. Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393 [TBL] [Abstract][Full Text] [Related]
17. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Konishi J; Yamazaki K; Tsukamoto E; Tamaki N; Onodera Y; Otake T; Morikawa T; Kinoshita I; Dosaka-Akita H; Nishimura M Respiration; 2003; 70(5):500-6. PubMed ID: 14665776 [TBL] [Abstract][Full Text] [Related]